News 10/4/24 – HIStalk
Top News
Virtual care chronic disease management vendor Omada Health files SEC paperwork for an IPO that is planned for early 2025.
The 13-year-old company has raised $450 million. It was valued at $1 billion in…
Top News
Virtual care chronic disease management vendor Omada Health files SEC paperwork for an IPO that is planned for early 2025.
The 13-year-old company has raised $450 million. It was valued at $1 billion in…
DarioHealth, a digital chronic-condition-management platform, announced it entered into a new contract with a national Medicare Advantage health plan and plans to launch its behavioral health initiative, Twill by Dario, for the plan’s members in…
Continue ReadingAt-home diagnostics company LetsGetChecked announced it has finalized its acquisition of digital pharmacy and telehealth startup Truepill.LetsGetChecked offers at-home tests for sexual health, diabetes, thyroid, cholesterol and COVID-19, while TruePill is an online digital…
Continue ReadingWhat You Should Know:
– Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management.
– Developed by Senseonics Holdings, Inc., Eversense 365 is…
Continue ReadingThousands of children and eligible adults living with type 1 diabetes across England will be able to receive an ‘artificial pancreas’ following cost-effective deals secured by the NHS with the technology’s suppliers.
The Hybrid Closed…
Background: The increasing prevalence of obesity necessitates innovative approaches to better understand this health crisis, particularly given its strong connection to chronic diseases such as diabetes, cancer, and cardiovascular conditions. Monitoring dietary behavior is…
Continue ReadingWhat You Should Know:
– DexCom, Inc., the global leader in real-time continuous glucose monitoring, and Beyond Type 2, a non-profit organization, are joining forces with actress Retta to launch the first-ever National Glucose Awareness…
Continue Reading– A recent study has shed light on the significant potential of the ECHO Model in improving diabetes care in rural communities.
– The research, published in The Journal of General Internal Medicine, showed that…
Continue ReadingWhat You Should Know:
– A research study by CCS, a leading chronic care management company, reveals that patients receiving continuous glucose monitoring (CGM) devices through medical benefits experience superior adherence and lower costs compared…
Continue ReadingWhat You Should Know:
– Senseonics Holdings, Inc. and Ascensia Diabetes Care announced that the FDA has cleared the Eversense® 365 CGM system.
– This marks a significant advancement in diabetes management, offering a fully-implantable, long-term…
Continue Reading